Plato Investment Management’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
OAM
DM
B
AIM
NAMA
Plato Investment Management's CDNA Position: Q3 2025 in Review
Plato Investment Management sold out of CareDx (CDNA) in Q3 2025, closing a stake of 47 shares — an estimated $915 sold.
Plato Investment Management first reported a position in CDNA in Q2 2024 and held it in 5 quarters. The position peaked at $125K in Q3 2024. 187 funds tracked by Wall St. Rank hold CDNA as of Q3 2025.
- Plato Investment Management reported no remaining CareDx position as of Q3 2025 after selling out during the quarter.
- Plato Investment Management sold 47 CareDx shares in Q3 2025, an estimated $915.
- Plato Investment Management first reported a position in CareDx in Q2 2024 and held it in 5 quarters.
- Plato Investment Management's CareDx position peaked at $125K in Q3 2024.
- 187 funds tracked by Wall St. Rank held CareDx as of Q3 2025.
Based on Plato Investment Management's 13F filing for Q3 2025, filed 5 Nov 2025.